Share

Development and validation of an analytical method for the measurement of plasma concentrations of Irinotecan and the metabolite SN-38 by liquid mass spectrometry.

Scientific collaboration with EUREKA - Lab Division srl

Project objectives

Monitoring of plasma concentrations of Irinotecan and metabolite SN-38 in cancer patients.

Start and end date
2017 - 2018

Project Manager
Prof. Pierantonio Menna, UR Clinical Pharmacology, Department of Science and Technology for Sustainable Development and One Health, Università Campus Bio-Medico di Roma; Campus Bio-Medico University Polyclinic Foundation - Principal Investigator
Prof. Girogio Minotti, Head of Pharmaceutical Sciences UR, Campus Bio-Medico University and Campus Bio-Medico University Polyclinic Foundation, Rome - Co-Principal Investigator
prof Emanuela Salvatorelli, UR Pharmaceutical Sciences, Campus Bio-Medico University, Rome - Co-Principal Investigator

Coordinating institution of the project
UR Pharmaceutical Sciences, Departmental Faculty of Medicine and Surgery, Integrated Research Center, Campus Bio-Medico University, Rome
2023© Università Campus Bio-Medico di Roma, Via Álvaro del Portillo, 21 - 00128 Rome, Tel. +39 06.22541.1, Fax +39 06.22541.456, VAT number: 048 020 51 005, Fiscal Code: 97087620585
QUICK LINKS
L'Università Campus Bio-Medico di Roma promotes integrated teaching and research structures, pursuing the good of the person as the main aim of its activities.
magnifiercrossmenuchevron-downchevron-leftchevron-right